Mergent, Inc. Announces Changes to the HealthShares(TM) European D... ( NEW YORK Aug. 11 /- Mergent Inc. ...)

Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index

Date:8/11/2008

NEW YORK, Aug. 11 /PRNewswire/ -- Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange Traded Funds, today announced the following change effective on the opening of trading on Thursday August 14, 2008: Biotest AG (Frankfurt, Germany: BIO) will replace Speedel Holding AG (SWX, Switzerland: SPPN) in the HealthShares(TM) European Drugs Index. Speedel Holding AG is being acquired by Novartis AG (SWX, Switzerland: NOVN).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080204/CLM073LOGO )

Companies included in the HealthShares(TM) European Drugs Index are headquartered in Europe and quoted on at least one European Stock Exchange that are engaged in the research, clinical development, manufacturing and commercialization of pharmaceutical products, small molecule/chemical moieties, biologics (proteins, peptides, oligoneucleotides, and cell/gene therapies) and vaccines, in all therapeutic categories, primarily intended for humans.

About Mergent

Mergent, Inc. is a leading provider of business and financial data on global publicly listed companies. Based in the U.S., the company maintains a strong global presence, with offices in New York, Charlotte, San Diego, London, Tokyo and Melbourne.

Founded in 1900, Mergent operates the longest continuously collected database of: descriptive and fundamental information on domestic and international companies; pricing and terms and conditions data on fixed income and equity securities; and corporate action data. In addition, Mergent develops and licenses equity and fixed income investment products based on its proprietary investment methodologies. Mergent-licensed products have approximately $3.5 billion in assets under management and are offered by major investment management firms. Mergent's index calculation platform is the chosen techn
'/>"/>

SOURCE Mergent, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line

Post Your Comments:

(Date:11/6/2009)...r 6 EUCODIS Bioscience, a company,...ing enzymes for the,chemical industry announced to...with Bio Sidus, the leading biopharmaceutical comp...es EUCODIS Bioscience exclusive access - for the s...ietary collection of,psychrophilic bacteria strain...

(Date:11/6/2009)...da for Arrowhead’s 2010 Personalized Medicin...ace on February 22-24, 2010 in Philadelphia, has b...l highlight key issues in forming partnerships and...es. , Minneapolis, MN (PR...rsquo;s 2010 Personalized Medicine Partnerships C...

(Date:11/5/2009)...e-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Boa...resident and CEO of Imagenetix, will be presenting...nference on Thursday, December 3rd, at 10:30 AM PS...D MICRO ,, LD MICRO is a by-invitation only new...ompanies in the micro-cap space. Since 2002, the f...

(Date:11/5/2009)...RNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) t...g at the following investor conferences, and invit... Credit Suisse Healthcare Conference, Ph...2009 at 10 a.m. Mountain Time, NA... Tuesday, 1 December, 2009 at 10.45 ...

Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2 Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2 Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3 Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2 Cepheid to Webcast Upcoming Financial Presentations 2

[0] EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus [0] Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference [0] Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air [0] Cepheid to Webcast Upcoming Financial Presentations

...2 Nektar,Therapeutics (Nasdaq: NKTR ) announced ...nsition from a drug delivery service provider to a...estructuring will,streamline the company, consolid...aking and execution within the business units., "... development company,and these changes are a natur...

...formance in 2007 and Notes Achievements over 4-ye... BioSciences, Preparing for Cha...ing-Plough,Corporation (NYSE: SGP ) today reporte...d full year, and commented on its ongoing integrat...cquired in November 2007 and,includes the Organon ...

...nternational,Corporation (Nasdaq: PRXL ) announce... 2-for-1 split of its Common Stock, which will be ...ers of PAREXEL,s Common Stock will receive one add...mmon Stock held on the record date of,February 22,...n or about,March 3, 2008 by PAREXEL,s transfer age...

Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year PAREXEL International Announces 2-For-1 Stock Split

(Date:11/4/2009)... 2009 Childhood obesity in the United States is r...ourth of advertising on daytime and prime time tel...ing questions about the role television plays in o...the Journal of Nutrition Education and Behavior ...ght be a large contributor to the problem. , Res...

(Date:11/4/2009)...hat deciphered the DNA codes, or genomes, of the f...joined The Genome 10K Project, an international ef...ences on 10,000 species of animals for conducting ...not be achieved. , Participating in The Genome 1...Nov. 5, 2009 issue of the Journal of Heredity , a...

(Date:11/4/2009)..., Oct. 19 Spectros, developer and ...ging devices which shed light on life-threatening ...sive distribution deals for both its T-Stat® ...red include Australia, New Zealand, The Netherlan..., France, Spain, Portugal, Poland, Greece, Turkey,...

Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2 TV bombards children with commercials for high-fat and high-sugar foods 3 Singapore scientists join international study of 10,000 vertebrates' genomes 2 Spectros Signs New International Distribution Deals 2 Donor Sperm Providers Form New Non Profit 59569 1 Oaks Development Group Launches Physician Incubator Space in Palm Coast Medical Office Building 59566 1 Oaks Development Group Launches Physician Incubator Space in Palm Coast Medical Office Building 59566 2 MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 14494 1 MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 14494 2 MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 14494 3

[0] TV bombards children with commercials for high-fat and high-sugar foods [0] Singapore scientists join international study of 10,000 vertebrates' genomes [0] Spectros Signs New International Distribution Deals

...reasing amounts of ice mass have been lost from We... past ten years, according to research from the Un... in Nature Geoscience. , Meanwhile the ice mass ...either loss nor accumulation over the past decade.... Bristol and colleagues estimated the flux of ice ...

...N ARBOR, Mich.---Common genetic variants linked to... new study shows. , The international study was c...ic Health. The journal Nature Genetics will publis...onfirms observations by health professionals of a ...risk of osteoarthritis, the most common form of ar...

...tudies involving more than 35,000 people and a sur...al team supported in part by the National Institut...genetic variants recently linked to osteoarthritis...indings were released today in the advance online ...e variants most strongly associated with height in...

Other Biology News:Antarctic ice loss 2 Study suggests genetic connection between short stature and arthritis 2 Researchers uncover new piece to the puzzle of human height 2 Researchers uncover new piece to the puzzle of human height 3 Researchers uncover new piece to the puzzle of human height 4

Antarctic ice loss Study suggests genetic connection between short stature and arthritis Researchers uncover new piece to the puzzle of human height

...tion. Cleaves a-(1-3)- and a(1-6)-linked, non-r...tes and glycoproteins. It is particularly efficien... where the pH must be neutral or above, for exampl...will hydrolyze 1 mole of p-nitrophenyl a-D-galacto...

ABI3100 Adapter for ABgene from ABgene

...2-Naphthoyl-VF-CHO White lyophilized solid. PROT...ermeable, reversible inhibitor of γ-secretas...40 (ED 50 = 2.6 μM) and Aβ x-42 (ED 50 ...ith the Amyloid Precursor Protein Swedish mutants....

Acl I (Psp1406 I) from New England Biolabs

Biology Products:

Escherichia coli alpha-Galactosidase Positionally specific solution from Sigma-Aldrich ABI3100 Adapter for ABgene from ABgene gamma-Secretase Inhibitor IV, Unconjugated from Calbiochem Acl I (Psp1406 I) from New England Biolabs

Mergent, Inc. Announces Changes to the HealthShares(TM) European D...( NEW YORK Aug. 11 /- Mergent Inc. ...)